✨ Medicines Consent Notices




NEW ZEALAND GAZETTE, No. 92 β€” 27 AUGUST 2015


2015-go5010

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Active Ingredient: Efmoroctocog alfa 250IU
Dosage Form: Powder with diluent
New Zealand Sponsor: Biogen Idec NZ Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany

ELOCTATE


Product:
Active Ingredient: Efmoroctocog alfa 500IU
Dosage Form: Powder with diluent
New Zealand Sponsor: Biogen Idec NZ Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany

ELOCTATE


Product:
Active Ingredient: Efmoroctocog alfa 750IU
Dosage Form: Powder with diluent
New Zealand Sponsor: Biogen Idec NZ Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany

ELOCTATE


Product:
Active Ingredient: Efmoroctocog alfa 1000IU
Dosage Form: Powder with diluent
New Zealand Sponsor: Biogen Idec NZ Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany

ELOCTATE


Product:
Active Ingredient: Efmoroctocog alfa 1500IU
Dosage Form: Powder for infusion
New Zealand Sponsor: Biogen Idec NZ Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany

ELOCTATE


Product:
Active Ingredient: Efmoroctocog alfa 2000IU
Dosage Form: Powder with diluent
New Zealand Sponsor: Biogen Idec NZ Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany

ELOCTATE


Product:
Active Ingredient: Efmoroctocog alfa 3000IU
Dosage Form: Powder with diluent
New Zealand Sponsor: Biogen Idec NZ Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany

ELOCTATE


Product:
Active Ingredients:

  • Glycopyrronium bromide 0.5mg/mL
  • Neostigmine metilsulfate 2.5mg/mL
    Dosage Form: Solution for injection
    New Zealand Sponsor: Boucher & Muir (NZ) Limited t/a Mercury Pharma (NZ)
    Manufacturer: B Braun Melsungen AG, Berlin, Germany

Glycopyrronium Bromide and Neostigmine Metilsulfate 0.5mg/2.5mg per mL


Product:
Active Ingredient: Ibuprofen 200mg
Dosage Form: Coated tablet
New Zealand Sponsor: Nova Pharmaceuticals NZ Limited
Manufacturer: Marksans Pharma Limited, Goa, India

MEDIX Ibuprofen

Dated this 24th day of August 2015.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister)

50



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2015, No 92





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
24 August 2015
Medicines, Consent, Distribution, New Zealand, Medicines Act 1981
  • CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health